Ads
related to: mrna stock news- Market Economy Trends
Review the Latest World
Markets Investment Insights.
- White Papers
Explore our Research Findings
on a Range of Topics.
- Fixed Income Outlook
View the Latest Fixed Income
Investment Insights.
- Fixed Income Capabilities
50 Years of Fixed Income Investing.
A Distinctive Approach. Learn More.
- Market Volatility
Insights on Current Conditions from
Our Investment Professionals.
- Inflation Rate News
Get Our Latest Thinking on
Inflation Rate Impacts.
- Market Economy Trends
Search results
mRNA Is Promising A Breakthrough In Fighting Cancer
Benzinga via Yahoo Finance· 10 hours agoWhen it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all...
Moderna stock gains on OpenAI deal (NASDAQ:MRNA)
Seeking Alpha· 6 days agoModerna (MRNA) stock gains as company announces a deal with AI company OpenAI to accelerate the development of new medicines. Read more here.
Cerity Partners LLC Grows Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 5 days agoCerity Partners LLC increased its position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 106.6% during the 4th quarter, according to the company in its most recent ...
Should You Buy Moderna Before May 12?
Motley Fool via Yahoo Finance· 4 days agoModerna's solid trial data makes me optimistic the FDA will offer mRNA-1345 a nod, so the company soon may have two products on the market -- and be...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 5 days agostock's 12-month performance. This means Moderna stock outranks almost half of all stocks on that...
A Fed meeting, jobs report, and more Big Tech earnings: What to know this week
Yahoo Finance via AOL· 17 hours ago...Coinbase (COIN), Cigna (CI), ConocoPhillips (COP), DraftKings (DKNG), Expedia (EXPE), Moderna (...
CureVac Shares Touch All-Time Low After Germany Deal Ends, Redesign News
Market Watch· 5 days agoShares of biopharmaceutical company CureVac touched a new low on Wednesday following news the company, together with GSK, ended a pandemic agreement with Germany and will ...
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Zacks via Yahoo Finance· 4 days agoOver the past six months, shares of MRNA have risen 36.47%. (See the last biotech stock roundup...
CureVac to cut costs in restructuring
BioPharma Dive via Yahoo Finance· 6 days agoThe mRNA vaccine maker, which has lost most of its value since early 2021, is undergoing an “organizational redesign” that will eliminate 150 positions.
CureVac (NASDAQ:CVAC) Shares Gap Up to $2.44
ETF DAILY NEWS· 6 days agoCureVac (NASDAQ:CVAC – Get Free Report) shares gapped up prior to trading on Monday . The stock had previously closed at $2.44, but opened at $2.51. CureVac shares last traded ...